These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 35980001

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Computational study of novel natural inhibitors targeting Kirsten rat sarcoma viral oncogene homolog G12C.
    Yang W, Ge J, Yuan M, Li J, Pan L, Ren J, Dou G, Yang L, Zhou Y, Xie H, Wang X, Hu H.
    Anticancer Drugs; 2023 Jun 01; 34(5):609-619. PubMed ID: 36847041
    [Abstract] [Full Text] [Related]

  • 3. Computational study on natural compounds inhibitor of c-Myc.
    Ren J, Huangfu Y, Ge J, Wu B, Li W, Wang X, Zhao L.
    Medicine (Baltimore); 2020 Dec 11; 99(50):e23342. PubMed ID: 33327259
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.
    Janes MR, Zhang J, Li LS, Hansen R, Peters U, Guo X, Chen Y, Babbar A, Firdaus SJ, Darjania L, Feng J, Chen JH, Li S, Li S, Long YO, Thach C, Liu Y, Zarieh A, Ely T, Kucharski JM, Kessler LV, Wu T, Yu K, Wang Y, Yao Y, Deng X, Zarrinkar PP, Brehmer D, Dhanak D, Lorenzi MV, Hu-Lowe D, Patricelli MP, Ren P, Liu Y.
    Cell; 2018 Jan 25; 172(3):578-589.e17. PubMed ID: 29373830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRASG12C.
    Mortier J, Friberg A, Badock V, Moosmayer D, Schroeder J, Steigemann P, Siegel F, Gradl S, Bauser M, Hillig RC, Briem H, Eis K, Bader B, Nguyen D, Christ CD.
    ChemMedChem; 2020 May 19; 15(10):827-832. PubMed ID: 32237114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
    Zhong S, Li W, Bai Y, Wu B, Wang X, Jiang S, Zhao Y, Ren J, Li H, Jin R.
    PLoS One; 2019 May 19; 14(5):e0216678. PubMed ID: 31120925
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting Krasg12c -mutant cancer with a mutation-specific inhibitor.
    Christensen JG, Olson P, Briere T, Wiel C, Bergo MO.
    J Intern Med; 2020 Aug 19; 288(2):183-191. PubMed ID: 32176377
    [Abstract] [Full Text] [Related]

  • 16. Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors.
    Zhu K, Li C, Wu KY, Mohr C, Li X, Lanman B.
    J Comput Aided Mol Des; 2022 Aug 19; 36(8):591-604. PubMed ID: 35930206
    [Abstract] [Full Text] [Related]

  • 17. Computational Study of Novel Natural Inhibitors Targeting O6-Methylguanine-DNA Methyltransferase.
    Yang L, Li W, Zhao Y, Zhong S, Wang X, Jiang S, Cheng Y, Xu H, Zhao G.
    World Neurosurg; 2019 Oct 19; 130():e294-e306. PubMed ID: 31203065
    [Abstract] [Full Text] [Related]

  • 18. Computational study on novel natural inhibitors targeting BCL2.
    Lv X, Jiang Y, Wang X, Xie H, Dou G, Wang J, Yang W, Wang H, Li Z, Zhang X, Chen Z.
    Med Oncol; 2021 Jul 14; 38(8):94. PubMed ID: 34259934
    [Abstract] [Full Text] [Related]

  • 19. Exploring Targeted Degradation Strategy for Oncogenic KRASG12C.
    Zeng M, Xiong Y, Safaee N, Nowak RP, Donovan KA, Yuan CJ, Nabet B, Gero TW, Feru F, Li L, Gondi S, Ombelets LJ, Quan C, Jänne PA, Kostic M, Scott DA, Westover KD, Fischer ES, Gray NS.
    Cell Chem Biol; 2020 Jan 16; 27(1):19-31.e6. PubMed ID: 31883964
    [Abstract] [Full Text] [Related]

  • 20. Selective apoptosis-inducing activity of synthetic hydrocarbon-stapled SOS1 helix with d-amino acids in H358 cancer cells expressing KRASG12C.
    Xu LL, Li CC, An LY, Dai Z, Chen XY, You QD, Hu C, Di B.
    Eur J Med Chem; 2020 Jan 01; 185():111844. PubMed ID: 31706640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.